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Research related to system approaches to uncovering the
characteristics of the TB bacillus grown in vivo could
ultimately be useful in discovering new immunodiagnos-
tic approaches. There are important differences between
a classic molecular biology view of genes and pheno-
types (one gene/one enzyme) and the systems-level
vision which focuses on identifying all the interactions
between genes and phenotypes. The systems approach
requires an in silico model to identify all the possible
genes and phenotypes. We have constructed such a
model and are using it to investigate differences between
in vivo Mycobacterium tuberculosis (M.tb) and in vitro
M.tb. It is known that in vitro M.tb behaves differently
from in vivo M.tb. For instance, M.tb in vitro is rela-
tively easy to rapidly kill with a single drug. Not in vivo,
however: the latter gives a two-hit pattern, suggesting
that a subpopulation of the bacteria is harder to kill,
even though they are still genetically susceptible. Is this
due to different gene expression patterns? If so, how do
we identify these? The genes that are specific to in vivo
TB may be useful in distinguishing between infection
and exposure and may be promising targets for new
drugs or imunodiagnostics. Using a systems biology
approach, our team has developed an approach that
could be used to identify these antigens.
We found some aspects of the in vivo state could be
simulated in vitro, using a culture system called a che-
mostat with a glycerol substrate to control the growth
rate of the bacillus. At a slow rate, the bacillus devel-
oped phenotypic drug tolerance. We then developed an
in silico genome-scale model, basically a mathematical
model of linked metabolic pathways to predict how
genes interact to generate the metabolism of the cell.
The model was tested by comparing gene essentiality
predictions with experimental data where it was shown
that the in silico model generated 78% correct predic-
tions. It was also able to predict the existence of a novel
metabolic pathway operating in slow-growing M.tb. The
M.tb model can also be used to interrogate transcrip-
tome date to identify signal metabolites. Our research
indicates that a systems approach may prove useful in
identifying novel immunodiagnostics for determining
whether a patient is infected with active or latent TB.
However, development of such immunodiagnostics will
first require identification of differences between M.tb
growing in acute and chronic lesions. Systems-based
approaches, such as we have described here, could be
used to identify such differences.
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